Arrow Jugular Puncture Kit 16 Ga.
510(k) K820009
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK820009 | Date22 Jan 1982 | StatusActive |
Recalls
-
- Ongoing Z-2377-2026
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
-
- Terminated Z-1243-2020
Product lidstock contains the incorrect expiration date for the product
-
- Terminated Z-1974-2018
Product sterility may be compromised due to unsealed packaging.
-
- Terminated Z-1331-2018
Certain lots of cardiovascular catheters may not be completely sealed and so sterility of the product cannot be guaranteed.
-
- Terminated Z-2328-2017
Arrow International is recalling the affected product because the packaging may not be completely sealed, which may compromise sterility.
-
- Terminated Z-1349-2011
- Terminated Z-1347-2011
- Terminated Z-1345-2011
- Terminated Z-1344-2011
- Terminated Z-1348-2011
Sterility may be compromised.
-
- Terminated Z-1494-2009
Leakage: Material not lipid resistant, may crack and/or leak. Use of this device with lipid containing solutions or 70% isopropyl alcohol may cause leakage or air embolism.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DQY
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1250
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
The Arrow Jugular Puncture Kit 16 Ga. is a medical device designed for percutaneous access to the jugular vein. It is classified under product code DQY and was determined to be substantially equivalent to a predicate device through the FDA 510(k) process.
The device received FDA 510(k) clearance under number K820009 on January 22, 1982, following a traditional review by the Cardiovascular advisory committee. It is manufactured by Arrow Intl., Inc. and is supplied as a kit for clinical use in vascular access procedures.
Other devices from Arrow Intl., Inc.
Questions
AI-generated answers, 26 Sep 2026
What is the Arrow Jugular Puncture Kit 16 Ga. used for?
The Arrow Jugular Puncture Kit 16 Ga. is designed for percutaneous access to the jugular vein, enabling clinicians to perform vascular access procedures by introducing a needle or catheter through the skin into the vein.
How is the Arrow Jugular Puncture Kit 16 Ga. supplied?
The device is supplied as a complete kit for clinical use, containing the necessary components for percutaneous jugular vein access, though specific kit contents are not detailed in the provided data.
What regulatory pathway was used for the Arrow Jugular Puncture Kit 16 Ga.?
The Arrow Jugular Puncture Kit 16 Ga. received FDA 510(k) clearance under number K820009 on January 22, 1982, following a traditional review process, which determined it to be substantially equivalent to a predicate device.